CCND1 and neoplasm: BRAF-wild-type clones present in primary tumours and metastases are likely to contain mutations or copy number alterations affecting genes other than BRAF, such as NRAS, KIT, cyclin D1, PTEN and CDKN2A (Curtin et al, 2005, 2006).